Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The mitochondrial carrier Citrin plays a role in regulating cellular energy during carcinogenesis


Citrin, encoded by SLC25A13 gene, is an inner mitochondrial transporter that is part of the malate–aspartate shuttle, which regulates the NAD+/NADH ratio between the cytosol and mitochondria. Citrullinemia type II (CTLN-II) is an inherited disorder caused by germline mutations in SLC25A13, manifesting clinically in growth failure that can be alleviated by dietary restriction of carbohydrates. The association of citrin with glycolysis and NAD+/NADH ratio led us to hypothesize that it may play a role in carcinogenesis. Indeed, we find that citrin is upregulated in multiple cancer types and is essential for supplementing NAD+ for glycolysis and NADH for oxidative phosphorylation. Consequently, citrin deficiency associates with autophagy, whereas its overexpression in cancer cells increases energy production and cancer invasion. Furthermore, based on the human deleterious mutations in citrin, we found a potential inhibitor of citrin that restricts cancerous phenotypes in cells. Collectively, our findings suggest that targeting citrin may be of benefit for cancer therapy.

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4


  1. Amoedo ND, Punzi G, Obre E, Lacombe D, De Grassi A, Pierri CL, et al. AGC1/2, the mitochondrial aspartate-glutamate carriers. Biochim Biophys Acta. 2016;1863:2394–412.

    CAS  Article  Google Scholar 

  2. Rabinovich S, Adler L, Yizhak K, Sarver A, Silberman A, Agron S, et al. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature. 2015;527:379–83.

    CAS  Article  Google Scholar 

  3. Satrustegui J, Pardo B, Del Arco A. Mitochondrial transporters as novel targets for intracellular calcium signaling. Physiol Rev. 2007;87:29–67.

    CAS  Article  Google Scholar 

  4. Song YZ, Deng M, Chen FP, Wen F, Guo L, Cao SL, et al. Genotypic and phenotypic features of citrin deficiency: five-year experience in a Chinese pediatric center. Int J Mol Med. 2011;28:33–40.

    PubMed  Google Scholar 

  5. Takeuchi S, Yazaki M, Yamada S, Fukuyama T, Inui A, Iwasaki Y, et al. An adolescent case of citrin deficiency with severe anorexia mimicking anorexia nervosa. Pediatrics 2015;136:e530–4.

    Article  Google Scholar 

  6. Saheki T, Inoue K, Tushima A, Mutoh K, Kobayashi K. Citrin deficiency and current treatment concepts. Mol Genet Metab 2010;100(Suppl 1):S59–64.

    CAS  Article  Google Scholar 

  7. Kimura N, Kubo N, Narumi S, Toyoki Y, Ishido K, Kudo D, et al. Liver transplantation versus conservative treatment for adult-onset type II citrullinemia: our experience and a review of the literature. Transplant Proc 2013;45:3432–7.

    CAS  Article  Google Scholar 

  8. Chang KW, Chen HL, Chien YH, Chen TC, Yeh CT. SLC25A13 gene mutations in Taiwanese patients with non-viral hepatocellular carcinoma. Mol Genet Metab 2011;103:293–6.

    CAS  Article  Google Scholar 

  9. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 2008;28:264–78.

    CAS  Article  Google Scholar 

  10. Komatsu M, Ichimura Y. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett. 2010;584:1374–8.

    CAS  Article  Google Scholar 

  11. Shinohara M, Adachi Y, Mitsushita J, Kuwabara M, Nagasawa A, Harada S, et al. Reactive oxygen generated by NADPH oxidase 1 (Nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration. J Biol Chem 2010;285:4481–8.

    CAS  Article  Google Scholar 

  12. Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 2007;23:164–70.

    CAS  Article  Google Scholar 

  13. Shaul YD, Yuan B, Thiru P, Nutter-Upham A, McCallum S, Lanzkron C, et al. MERAV: a tool for comparing gene expression across human tissues and cell types. Nucleic Acids Res. 2015;44(D1):D560–6.

    Article  Google Scholar 

  14. Fiermonte G, Parisi G, Martinelli D, De Leonardis F, Torre G, Pierri CL, et al. A new Caucasian case of neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD): a clinical, molecular, and functional study. Mol Genet Metab 2011;104:501–6.

    CAS  Article  Google Scholar 

  15. Corbet C, Bastien E, Draoui N, Doix B, Mignion L, Jordan BF, et al. Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects. Nat Commun. 2018;9:1208.

    Article  Google Scholar 

  16. van Niekerk G, Engelbrecht AM. Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target. Cell Oncol (Dordrecht). 2018;14:343–51.

  17. Porporato PE, Payen VL, Perez-Escuredo J, De Saedeleer CJ, Danhier P, Copetti T, et al. A mitochondrial switch promotes tumor metastasis. Cell Rep 2014;8:754–66.

    CAS  Article  Google Scholar 

  18. Kluza J, Corazao-Rozas P, Touil Y, Jendoubi M, Maire C, Guerreschi P, et al. Inactivation of the HIF-1alpha/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants. Cancer Res 2012;72:5035–47.

    CAS  Article  Google Scholar 

  19. Sullivan LB, Luengo A, Danai LV, Bush LN, Diehl FF, Hosios AM, et al. Aspartate is an endogenous metabolic limitation for tumour growth. Nat Cell Biol. 2018;20:782–8.

    CAS  Article  Google Scholar 

  20. Garcia-Bermudez J, Baudrier L, La K, Zhu XG, Fidelin J, Sviderskiy VO, et al. Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat Cell Biol. 2018;20:775–81.

    CAS  Article  Google Scholar 

  21. Gaude E, Schmidt C, Gammage PA, Dugourd A, Blacker T, Chew SP, et al. NADH shuttling couples cytosolic reductive carboxylation of glutamine with glycolysis in cells with mitochondrial dysfunction. Mol Cell 2018;69:581–93.e7.

    CAS  Article  Google Scholar 

  22. Hollinshead KE, Tennant DA. Mitochondrial metabolic remodeling in response to genetic and environmental perturbations. Wiley Inter Rev Syst Biol Med. 2016;8:272–85.

    CAS  Article  Google Scholar 

  23. Xian ZY, Liu JM, Chen QK, Chen HZ, Ye CJ, Xue J, et al. Inhibition of LDHA suppresses tumor progression in prostate cancer. Tumour Biol 2015;36:8093–100.

    CAS  Article  Google Scholar 

  24. Erez A, DeBerardinis RJ. Metabolic dysregulation in monogenic disorders and cancer - finding method in madness. Nat Rev Cancer. 2015;15:440–8.

    CAS  Article  Google Scholar 

  25. Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, et al. The metabolic co-regulator PGC1alpha suppresses prostate cancer metastasis. Nat Cell Biol. 2016;18:645–56.

    CAS  Article  Google Scholar 

  26. Chung HY, Park YK. Rationale, feasibility and acceptability of ketogenic diet for cancer treatment. J Cancer Prev 2017;22:127–34.

    Article  Google Scholar 

  27. Fass E, Shvets E, Degani I, Hirschberg K, Elazar Z. Microtubules support production of starvation-induced autophagosomes but not their targeting and fusion with lysosomes. J Biol Chem 2006;281:36303–16.

    CAS  Article  Google Scholar 

  28. Hung YP, Albeck JG, Tantama M, Yellen G. Imaging cytosolic NADH-NAD(+) redox state with a genetically encoded fluorescent biosensor. Cell Metab 2011;14:545–54.

    CAS  Article  Google Scholar 

  29. Salem M, Bernach M, Bajdzienko K, Giavalisco P. A simple fractionated extraction method for the comprehensive analysis of metabolites, lipids, and proteins from a single sample. J Vis Exp. 2017;1:124.

    Google Scholar 

  30. Malitsky S, Ziv C, Rosenwasser S, Zheng S, Schatz D, Porat Z, et al. Viral infection of the marine alga Emiliania huxleyi triggers lipidome remodeling and induces the production of highly saturated triacylglycerol. New Phytol 2016;210:88–96.

    CAS  Article  Google Scholar 

  31. Zheng L, Cardaci S, Jerby L, MacKenzie ED, Sciacovelli M, Johnson TI, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001.

    CAS  Article  Google Scholar 

  32. Robinson BH, McKay N, Goodyer P, Lancaster G. Defective intramitochondrial NADH oxidation in skin fibroblasts from an infant with fatal neonatal lacticacidemia. Am J Hum Genet 1985;37:938–46.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Dimmock D, Maranda B, Dionisi-Vici C, Wang J, Kleppe S, Fiermonte G, et al. Citrin deficiency, a perplexing global disorder. Mol Genet Metab 2009;96:44–9.

    CAS  Article  Google Scholar 

  34. Dimmock D, Kobayashi K, Iijima M, Tabata A, Wong LJ, Saheki T, et al. Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet. Pediatrics 2007;119:e773–7.

    Article  Google Scholar 

  35. Dimmock D, Tang LY, Schmitt ES, Wong LJ. Quantitative evaluation of the mitochondrial DNA depletion syndrome. Clin Chem. 2010;56:1119–27.

    CAS  Article  Google Scholar 

  36. Bartolome F, Abramov AY. Measurement of mitochondrial NADH and FAD autofluorescence in live cells. Methods Mol Biol (Clifton, NJ) 2015;1264:263–70.

    CAS  Article  Google Scholar 

Download references


We acknowledge and thank the Weizmann Institute for providing financial and infrastructural support. We thank Tomer Shlomi and his student Won Dong-Lee, Gad Asher, Zvulun Elazar and his student Adi Abada, Yoav Shaul, Irit Sagi, Ron Rotkopf, and Sivan Galai for the intellectual and technical assistance. AE is incumbent of the Leah Omenn Career Development Chair and is supported by research grants from the European research program (CIG618113, ERC614204), the Israel Science Foundation (1343/13; 1952/13), and from the Minerva grant award (711730). AE received additional support from the Adelis Foundation, the Henry S. and Anne S. Reich Research Fund, the Dukler Fund for Cancer Research, the Paul Sparr Foundation, the Saul and Theresa Esman Foundation, from Joseph Piko Baruch, and from the estate of Fannie Sherr. The authors declare applying for a patent for citrin inhibition as cancer therapy.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Ayelet Erez.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rabinovich, S., Silberman, A., Adler, L. et al. The mitochondrial carrier Citrin plays a role in regulating cellular energy during carcinogenesis. Oncogene 39, 164–175 (2020).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links